SCHEMBL4039550

SCHEMBL4039550

O=C(NC1CCCCC1)C(C1CCCCC1)C1(c2ccc(-c3ccc(Cl)c(Cl)c3)cc2)Nc2ccccc2N1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.44
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
SLC6A3 Q01959 3/20 0.40
SLC6A2 P23975 1/20 0.40
NR1H4 Q96RI1 5/20 0.38
CYP3A4 P08684 2/20 0.37
KCNH2 Q12809 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
TSHR P16473 1/20 0.36
FAAH O00519 1/20 0.36
MAPT P10636 1/20 0.36
ALOX12 P18054 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4040656 0.92 LMNA (0.45) LMNANPC1RAB9AMEN1KMT2A
SCHEMBL4039101 0.86 NR1H4 (0.44) NPC1RAB9AMEN1KMT2ANR1H4
SCHEMBL4042732 0.86 NR1H4 (0.44) NPC1RAB9AMEN1KMT2ANR1H4
SCHEMBL4039953 0.86 NPC1 (0.40) LMNANPC1RAB9AMEN1KMT2A
SCHEMBL4041199 0.84 SMN1; SMN2 (0.47) LMNANPC1RAB9AMEN1KMT2A
SCHEMBL4044540 0.84 NR1H4 (0.44) LMNANPC1RAB9ANR1H4CYP3A4
SCHEMBL4040480 0.84 NR1H4 (0.44) LMNANPC1RAB9ANR1H4CYP3A4
SCHEMBL4042940 0.84 TSHR (0.45) LMNANPC1RAB9AMEN1KMT2A
SCHEMBL4044551 0.84 CYP3A4 (0.42) LMNANPC1RAB9AMEN1KMT2A
SCHEMBL4045309 0.84 TRPV1 (0.41) LMNAMEN1KMT2ACYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed